Connecting minds, sparking collaboration

Olink Biomarker
Summit Series

Unveil the power of proteins in biomarker discovery

Power of Proteins in Biomarker Discovery

The Olink Biomarker Summit Series is a networking event for biomarker researchers working in human disease. We will be gathering local researchers in Houston, Boston, Montreal, and San Francisco to engage with KOLs from academia and pharma as they delve into the power of Olink Technology to discover and analyze protein biomarkers in a broad range of applications. Registration is free for all summits. Accelerate your research and connect with experts in your field at this informative series.

Locations

Olink User Workshop - Boston | April 30, 2024 | Invite only (Password required to register)

This event is designed for Olink trained users who have internalized our technology. Meet with other Olink trained users and exchange experiences and share ideas. Throughout the day, there will be presentations from Olink leaders, refreshments, and networking opportunities.

Venue: Boston Museum of Science

Register for Olink User Workshop

Agenda

8:30 a.m. | Check-in

9:00 a.m. | Olink validation in your lab

9:30 a.m. | Breakout sessions – Choose 1
Breakout 1: Olink midplex data review – hands on practice
Breakout 2: Discover more with less – positioning Olink midplex products

10:30 a.m. | Coffee break

11:00 a.m. | Olink Insight – A knowledge platform for proteomics

11:30 a.m. | Exploring the data science ecosystem

12:00 p.m. | Ensuring data accuracy – Olink® Concordance test and Olink® Certified Service Provider Program

12:30 p.m. | Lunch

1:30 p.m. | Mastering data science with Olink Analyze: A comprehensive training guide

2:00 p.m. | Olink Analysis Service – Large scale proteomics

2:30 p.m. | Highplex QC – New to Olink software

3:00 p.m. | Breakout sessions – Choose 1
Breakout 3: Olink highplex data review – hands on practice
Breakout 4: Positioning Olink highplex solutions and moving from Olink® Explore 3k to Explore HT

4:00 p.m. | Coffee break

4:30 p.m. | Olink round table

Olink Biomarker Summit – Boston | May 1, 2024

The Olink Biomarker Summit Series is arriving in the number one Biotech hub in the world, Boston, Massachusetts. This event offers you the opportunity to network with other local biomarker researchers who are leading the future of proteomics. Attendees have the exclusive chance to ask questions and engage in-person with key opinion leaders from the area who will be presenting their Olink data. 

Venue: Boston Museum of Science

Register for the Boston Summit

Agenda

8:00 a.m. | Registration 

8:30 a.m. | Welcome introduction - Carl Raimond, President, Olink Proteomics, Inc.

9:00 a.m. | Quantitative high sensitivity multiplex proteomic platform comparison - Peter Schafer, PhD, Scientific Vice President, Immunology, Cardiovascular, and Neurology Translational Medicine Disease Team, Bristol Myers Squibb

9:35 a.m. | Inflammatory biomarker associations with cognitive function testing, brain MRI phenotypes, incident dementia and Alzheimer’s disease - Peggy Doyle, PhD, Associate Professor of Pathology and Laboratory Medicine; Director, Laboratory for Clinical Biochemistry Research Larner College of Medicine, University of Vermont

10:10 a.m. | Coffee break

10:30 a.m. | High-throughput Proteomics-assisted Biomarker Identification in Neurodegenerative Diseases – Alvis Hu, PhD, Principal Scientist II and Head of Genomic Technologies, Genomics Research Center, AbbVie Inc.

11:05 a.m. | Olink applications in inflammatory skin diseases - Helen He, MD, Dermatology PGY-4 Resident, Icahn School of Medicine at Mount Sinai

11:45 a.m. | Lunch

1:15 p.m. | Olink Insight – an online knowledge and analytics portal for proteomics - Kristin Hellman, MSc, Product Manager, Olink Proteomics, Inc.

1:50 p.m. | Joslin kidney panel of circulating proteins predicting risk of kidney failure as instrument of precision medicine to improve care of diabetic kidney disease - Andrzej Krolewski, MD, PhD, Senior Investigator, Joslin Diabetes Center; Professor of Medicine, Harvard Medical School

2:25 p.m. | Coffee break

2:40 p.m. | Guest Speakers

3:15 p.m. | Keynote speaker – Rob Gerszten, MD, Chief of Cardiology, Beth Israel Deaconess Medical Center

3:50 p.m. | Closing remarks

4:00 p.m. | Coffee reception


Meet some of our speakers


Rob Gerszten, MD
Chief of Cardiology, Beth Israel Deaconess Medical Center


Peter Schafer, PhD
Scientific Vice President, Immunology, Cardiovascular, and Neurology Translational Medicine Disease Team, Bristol Myers Squibb


Peggy Doyle, PhD
Associate Professor of Pathology and Laboratory Medicine; Director, Laboratory for Clinical Biochemistry Research Larner College of Medicine, University of Vermont


Alvis Hu, PhD
Principal Scientist II and Head of Genomic Technologies, Genomics Research Center, AbbVie Inc.


Helen He, MD
Dermatology PGY-4 Resident, Icahn School of Medicine at Mount Sinai


Andrzej Krolewski, MD, PhD
Senior Investigator, Joslin Diabetes Center; Professor of Medicine, Harvard Medical School


Kristin Hellman, MSc 
Product Manager, Olink Proteomics, Inc


Carl Raimond
President, Olink Proteomics, Inc.

Olink Biomarker Summit - Montreal | May 7, 2024

The Olink Biomarker Summit Series is coming to Montreal, Canada, offering our Canadian Olink community the opportunity to network with other local biomarker researchers immersed in human disease studies. During the event, attendees will learn and engage local Olink experts and with key-opinion-leaders utilizing Olink technology to make novel discoveries. and local Olink experts. This event promises to be a catalyst for insightful discussions and invaluable connections.

Venue: The PGSS Thomson House

Agenda

9:00 a.m. | Registration & coffee

9:30 a.m. | Welcome introduction to Olink Proteomics – Eric Leblond, Canada Country Manager, Olink Proteomics, Inc.

9:35 a.m. | Enabling proteomics at global scale – Evan Mills, VP, Global Strategic Accounts, Olink Proteomics, Inc.

10:00 a.m. | Olink Proteomics’ PEA technology and workflow overview – Shana Lamers, MS, Field Application Scientist, Olink Proteomics, Inc.

10:30 a.m. | Serum proteomic analyses to advance our understanding of biological and clinical heterogeneity in patients with Ulcerative Colitis and Crohn’s Disease – John Rioux, PhD, Full Professor of Medicine, Montreal Heart Institute; Canada Research Chair in Genetics and Genomic Medicine, Université de Montréal, Canadian Institutes of Health Research

11:15 a.m. | Coffee break

11:30 a.m. | Empowering genomics and biomarker discovery through broad scale proteomics – Cindy Lawley, PhD, Senior Director, Population Health

12:00 p.m. | Discovery a new biomarkers in sickle cell disease – Guillaume Lettre, PhD, Professor of Medicine, Université de Montréal and Montreal Heart Institute; Canada Research Chair in Genetics of Heart and Blood Diseases; Fellow of the College of the Royal Society of Canada

12:30 p.m. | Lunch

1:15 p.m. | Harnessing proteomics for diagnostic and prognostic insights into cancer – Michael Förster, PhD, Scientific Director Oncology, Olink Proteomics, Inc.

1:45 p.m. | Use of Olink PEA technology to identify high value CSF biomarkers in pre-symptomatic elderly subjects with a parental history of Alzheimer’s disease – Judes Poirier, PhD, MD (Hon), K.Q., Deputy Director, McGill University

2:30 p.m. | Multiomics in precision medicine panel discussion – Panel discussion: Moderator – Cindy Lawley, PhD.

3:00 p.m. | Closing remarks – Eric Leblond, Canada Country Manager, Olink Proteomics, Inc.

3:05 p.m. – 4:30 p.m. | Happy hour


Meet some of our speakers


John Rioux, PhD
Full Professor of Medicine, Montreal Heart Institute; Canada Research Chair in Genetics and Genomic Medicine, Université de Montréal, Canadian Institutes of Health Research


Judes Poirier, PhD, MD (Hon), K.Q.
Deputy Director, McGill University


Shana Lamers, MS
Field Application Scientist, Olink Proteomics, Inc.


Evan Mills
Vice President of Americas Sales


Michael Förster, PhD
Scientific Director Oncology, Olink Proteomics, Inc.


Cindy Lawley, PhD
Senior Director, Global Population Health, Olink Proteomics, Inc.


Guillaume Lettre, PhD
Professor of Medicine, Université de Montréal and Montreal Heart Institute; Canada Research Chair in Genetics of Heart and Blood Diseases; Fellow of the College of the Royal Society of Canada

 

Olink Biomarker Summit – San Francisco | May 21, 2024

The Olink Biomarker Summit Series’ final stop is in San Francisco. Attendees will have the opportunity to network with other local biomarker researchers immersed in human disease studies. Key-opinion-leaders will be presenting their Olink data and taking questions from attendees.

Venue: AC Hotel by Marriott San Francisco Airport/Oyster Point Waterfront

Register for the San Francisco Summit

Agenda

11:30 a.m. | Registration, lunch & networking

12:30 p.m. | Welcome introduction – Tal Varsano, PhD, Business Development Manager, Olink Proteomics, Inc.

12:40 p.m. | Proteomic predictors of morbidity and mortality in treated HIV and asymptomatic CMV - Peter W. Hunt, MD, Professor of Medicine in the Division of Experimental Medicine (DEM) at the University of California San Francisco; Associate Chief for Research for the ZSFG-UCSF Department of Medicine

1:15 p.m. | Harnessing proteomics for enhanced understanding of myelin and axonal health - Ahmed Abdelhak, MD, HS Clinical Instructor, Division of Neuroinflammation and Glial Biology, Dept. of Neurology, University of California San Francisco

1:50 p.m. | Coffee break

2:10 p.m. | Circulatory prostate cancer proteome landscapes and prognostic biomarkers in metastatic castrate resistant prostate cancer - Manish Kohli MD, Professor, Division of Oncology, School of Medicine; Director, Physician Scientist Training Program, Department of Internal Medicine, Huntsman Cancer Institute, Salt Lake City, UT

2:45 p.m. | Guest speaker

3:20 p.m. | Panel discussion (Abbvie, Alkahest, and Genentech) – Multi-Omics Integration for the Design of Novel Therapies – Moderated by Cindy Lawley, PhD, Sr Director, Global Population Health, Olink Proteomics, Inc.

3:50 p.m. | Closing remarks

4:00 p.m. | Happy hour


Meet some of our speakers


 Peter Hunt, MD
Professor of Medicine in the Division of Experimental Medicine (DEM) at the University of California San Francisco; Associate Chief for Research for the ZSFG-UCSF Department of Medicine


Manish Kohli MD
Professor, Division of Oncology, School of Medicine; Director, Physician Scientist Training Program, Department of Internal Medicine, Huntsman Cancer Institute, Salt Lake City, UT


Ahmed Abdelhak, MD
HS Clinical Instructor, Division of Neuroinflammation and Glial Biology, Dept. of Neurology, University of California San Francisco

 

Event passed – Olink Biomarker Summit – Houston | April 2, 2024 | 11:30 AM – 5:00 PM CDT

The Olink Biomarker Summit Series is arriving in the beautiful city of Houston, Texas, offering you the opportunity to network with other biomarker researchers immersed in human disease studies. With presentations from key opinion leaders and local experts on site, this event promises to be a catalyst for insightful discussions and invaluable connections.

Venue: The Westin Houston Medical Center/Museum District

A celebratory happy hour for all attendees will begin at 5:00 PM CDT at the venue.

Agenda 

11:30 a.m. | Check in and lunch served 

12:00 p.m. | Introductions – Joe Albert, Director of Business Development- West, Olink Proteomics, Inc. 

12:10 p.m. | Opening remarks: Proteomics: From discovery to clinical practice – Christie Ballantyne, MD, Professor, Department of Medicine; Chief, Section of Cardiovascular Research; Director, Center for Cardiometabolic Disease Prevention, Baylor College of Medicine 

12:30 p.m. | Longitudinal proteomic exploration of subacute and chronic morbidity in children with congenital heart disease – Jesse Davidson, MD, MPH, MSc, Associate Professor, Pediatrics-Cardiology, University of Colorado

1:10 p.m. | Coffee and tea break 

1:30 p.m. | Omics technologies in commercial spaceflight research – Harsha Doddapaneni, PhD, Associate Professor, Department of Molecular and Human Genetics, BCM Human Genome Sequencing Center (HGSC) 

2:00 p.m. | The Octave MSDA test product journey: Improving insights for patients with MS utilizing a clinically validated assay developed on the Olink platform – Ferhan Qureshi, Vice President, Biomarker Product Development, Octave Bio 

2:50 p.m. | Coffee and tea break

3:10 p.m. | Harnessing proteomics for diagnostic and prognostic insights in cancer research – Michael Förster, PhD, Scientific Director, Oncology & Rare Disease, Olink Proteomics, Inc. 

4:00 p.m. | Multi-omics analysis reveals immune features associated with immunotherapy benefit in squamous cell lung cancer patients – Edwin Parra, MD, PhD, Associate Professor and Director of the Multiplex Immunofluorescence and Image Analysis Laboratory in the Department of Translational Molecular Pathology at The University of Texas MD Anderson Cancer Center 

4:45 p.m. | Closing remarks

5:00 p.m. | Celebratory happy hour


Meet some of our speakers


Ferhan Qureshi
Vice President Biomarker Product Development, Octave Bioscience


Christie Ballantyne, MD
Professor, Department of Medicine; Chief, Section of Cardiovascular Research; Director, Center
for Cardiometabolic Disease Prevention, Baylor College of Medicine


Harsha Doddapaneni, PhD
Associate Professor, Department of Molecular and Human Genetics, BCM Human Genome Sequencing Center (HGSC)


Michael Förster, PhD
Scientific Director, Oncology & Rare Disease, Olink Proteomics, Inc.


Edwin Parra, MD, PhD
Associate Professor and Director of the Multiplex Immunofluorescence and Image Analysis Laboratory in the Department of Translational Molecular Pathology at The University of Texas MDAnderson Cancer Center


Jesse Davidson, MD, MPH, MSc
Associate Professor, Pediatrics-Cardiology, University of Colorado

 

Connecting minds, sparking collaboration

Register for one of the Biomarker Summits